Theravance Biopharma TBPH Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by Theravance Biopharma in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Theravance Biopharma's change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Theravance Biopharma's change in accrued liabilities?
- Theravance Biopharma (TBPH) reported change in accrued liabilities of -$4.87M in Q1 2026.
- How has Theravance Biopharma's change in accrued liabilities changed year-over-year?
- Theravance Biopharma's change in accrued liabilities decreased by 221.5% year-over-year, from -$1.51M to -$4.87M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.